- Home
- THFF vs CRMD Comparison
THFF vs CRMD Comparison
Compare THFF & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | THFF | CRMD |
|---|---|---|
| Founded | 1984 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 721.3M | 958.1M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | THFF | CRMD |
|---|---|---|
| Price | $62.96 | $6.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $60.00 | $17.29 |
| AVG Volume (30 Days) | 52.0K | ★ 4.0M |
| Earning Date | 02-03-2026 | 11-12-2025 |
| Dividend Yield | ★ 3.54% | N/A |
| EPS Growth | ★ 69.68 | N/A |
| EPS | ★ 6.25 | 2.25 |
| Revenue | ★ $250,755,000.00 | $214,303,672.00 |
| Revenue This Year | $33.24 | $628.67 |
| Revenue Next Year | $8.15 | $14.64 |
| P/E Ratio | $10.11 | ★ $3.11 |
| Revenue Growth | 31.89 | ★ 1647.67 |
| 52 Week Low | $42.05 | $5.60 |
| 52 Week High | $65.79 | $17.43 |
Technical Indicators
Market Signals| Indicator | THFF | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 55.74 | 22.73 |
| Support Level | $60.50 | $7.01 |
| Resistance Level | $63.49 | $7.44 |
| Average True Range (ATR) | 1.38 | 0.66 |
| MACD | -0.01 | -0.53 |
| Stochastic Oscillator | 81.86 | 0.40 |
Price Performance
Historical ComparisonAbout THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.